Last edition
News about "sotrovimab to treat Covid-19"
Covid 19 treatment: Vir Biotechnology receives AustralianTGA marketing approval for sotrovimab
Vir Biotechnology announced the first marketing authorization, granted in Australia, for its first commercial product, sotrovimab, developed in partnership with GlaxoSmithKline (GSK). This announcement follows news shared by GSK Australia that the Australian Therapeutic Goods Administration (TGA) has granted provisional marketing authorization
Sotrovimab To Treat Covid-19 | 25/08/2021 | By Darshana | 230
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy